ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 51 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2018. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $38,000 | -38.7% | 29,338 | 0.0% | 0.00% | – |
| Q1 2019 | $62,000 | -6.1% | 29,338 | 0.0% | 0.00% | – |
| Q4 2018 | $66,000 | -35.9% | 29,338 | 0.0% | 0.00% | – |
| Q3 2018 | $103,000 | +9.6% | 29,338 | 0.0% | 0.00% | – |
| Q2 2018 | $94,000 | -8.7% | 29,338 | 0.0% | 0.00% | – |
| Q1 2018 | $103,000 | -20.2% | 29,338 | 0.0% | 0.00% | – |
| Q4 2017 | $129,000 | -15.7% | 29,338 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $153,000 | 0.0% | 29,338 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $153,000 | +22.4% | 29,338 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $125,000 | +35.9% | 29,338 | 0.0% | 0.00% | – |
| Q4 2016 | $92,000 | -8.9% | 29,338 | 0.0% | 0.00% | – |
| Q3 2016 | $101,000 | +23.2% | 29,338 | 0.0% | 0.00% | – |
| Q2 2016 | $82,000 | – | 29,338 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARD ASSOCIATES INC | 124,300 | $87,000 | 0.04% |
| Hayden Royal, LLC | 16,000 | $12,272,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $16,000 | 0.01% |
| Founders Capital Management | 8,000 | $6,000 | 0.01% |
| Cable Hill Partners, LLC | 20,000 | $14,000 | 0.00% |
| Jacobi Capital Management LLC | 25,000 | $18,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 22,000 | $15,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 37,520 | $27,000 | 0.00% |
| Firestone Capital Management | 5,200 | $4,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $7,000 | 0.00% |